Yahoo! Finance: Top Stories

aTyr Pharma, Inc. (ATYR): Analysts See 485% Upside Potential

May 21, 2025 - 16:42
 0
aTyr Pharma, Inc. (ATYR): Analysts See 485% Upside Potential
Read More

Tags:

Previous Article

Perspective Therapeutics, Inc. (CATX): Analysts See 460% Upside Potential

Next Article

AbCellera Biologics Inc. (ABCL): Analysts See 474% Upside Potential

Related Posts

GlobalWafers to spend additional $4B on US manufacturing

GlobalWafers to spend additional $4B on US manufacturing

May 17, 2025  0

Family Tracker App Life360 Finds Mixed First-Quarter Report

Family Tracker App Life360 Finds Mixed First-Quarter Re...

May 14, 2025  0

Thoma Bravo Sells Remaining $3.4 Billion Nasdaq Stake

Thoma Bravo Sells Remaining $3.4 Billion Nasdaq Stake

May 17, 2025  0